The Fall and Winter issue of Northwestern Research Magazine, which highlights the discoveries of Northwestern scholars, focuses on interdisciplinary cognitive science, including several Feinberg scientists.
A new Northwestern Medicine study addresses challenges at the PhD level to boost the persistence of underrepresented minority and female students toward academic careers.
Injections of botulinum toxin improved active arm movement for stroke and brain trauma patients in a clinical trial that involved Northwestern Medicine co-investigator Christina Marciniak, MD, ’85 GME.
Douglas Wilcox, a student in the Medical Scientist Training Program, discovered the herpes simplex virus targets a host cell protein to cause severe disease and encephalitis in newborns.
A specially developed nanoparticle may be able to prevent progression of multiple sclerosis triggered by the death of brain cells that make the insulation around nerve fibers.
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
Gregory Schwartz, PhD, assistant professor of Ophthalmology and Physiology, and his lab map neural circuits in the retina that send visual information to the brain, work that could inform future treatments for blindness.
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
A new Northwestern Medicine study highlighted for the first time how a toxin from the extracellular bacterium Vibrio cholerae can inhibit autophagy and endosomal trafficking.
Blocking the sodium channel protein Nax decreased scarring and atopic dermatitis, an inflammatory skin disorder, by improving the skin’s barrier function in a new Northwestern Medicine study.